| 序号 | 专利名 | 申请号 | 申请日 | 公开（公告）号 | 公开（公告）日 | 发明人 |
|---|---|---|---|---|---|---|
| 81 | METHOD TO SEPARATE LIPIDS FROM CHEESE WHEY AND FAT-FREE WHEY PROTEIN PRODUCT FORMED THEREBY | EP09792706.5 | 2009-09-18 | EP2346342A1 | 2011-07-27 | DAMODARAN, Srinivasan |
| Disclosed is a method of selectively separating milk fat globule membrane fragments and milk fat globules from whey. The method includes the steps of adding to whey an amount of a whey-soluble zinc salt and adjusting the pH of the whey to be less than 6.0. The amount of zinc salt added to the whey is sufficient to cause milk fat globule membrane fragments and milk fat globules contained in the whey to precipitate selectively from the whey. | ||||||
| 82 | Milk fat for the treatment of mucositis | EP11161639.7 | 2008-05-14 | EP2345418A1 | 2011-07-20 | Kanwar, Jagat, Rakesh; Krissansen, Geoffrey, Wayne; Sun, Xueying; Palmano, Kay, Patricia; MacGibbon, Alastair, Kenneth, Hugh |
The present invention relates to administration of milk fat or a milk fat analogue, optionally with at least one additional therapeutic factor, preferably lactoferrin or metal ion lactoferrin, preferably iron lactoferrin, preferably bovine lactoferrin, preferably iron bovine lactoferrin, or a metal ion functional variant or functional fragment thereof, to treat mucositis. |
||||||
| 83 | COMPOSITIONS COMPRISING PHOSPHOLIPIDS | EP08782939 | 2008-08-15 | EP2178539A4 | 2011-05-04 | BROWN ANDREW; ROWNEY MICHELLE |
| 84 | BETA-SERUM DAIRY PRODUCTS, NEUTRAL LIPID-DEPLETED AND/OR POLAR LIPID-ENRICHED DAIRY PRODUCTS, AND PROCESSES FOR THEIR PRODUCTION | EP05801035 | 2005-10-12 | EP1814399A4 | 2011-03-23 | KATRINA FLETCHER; OWEN JOHN CATCHPOLE; JOHN BERTRAM GREY; MARK PRITCHARD |
| 85 | METHODS OF IMMUNE OR HEMATOLOGICAL ENHANCEMENT, INHIBITING TUMOUR FORMATION OR GROWTH, AND TREATING OR PREVENTING CANCER, CANCER SYMPTOMS, OR THE SYMPTOMS OF CANCER TREATMENTS | EP08766954.5 | 2008-05-14 | EP2146739A2 | 2010-01-27 | KANWAR, Jagat, Rakesh; KRISSANSEN, Geoffrey, Wayne; SUN, Xueying; PALMANO, Kay, Patricia; MACGIBBON, Alastair, Kenneth, Hugh |
| The present invention relates to administration of milk fat or a milk fat analogue, optionally with at least one additional therapeutic factor, preferably lactoferrin or metal ion lactoferrin, preferably iron lactoferrin, preferably bovine lactoferrin, preferably iron bovine lactoferrin, or a metal ion functional variant or functional fragment thereof, to inhibit tumour formation or growth, maintain or improve one or more of the white blood cell count, the red blood cell count, or the myeloid cell count, reduce cachexia, mucositis, and anemia, stimulate the immune system and treat or prevent cancer and the symptoms of cancer and side-effects of cancer therapies. The methods and medicinal uses of the invention may be carried out by employing dietary (as foods or food supplements), nutraceutical or pharmaceutical compositions. Compositions useful in the methods of the invention are also provided. | ||||||
| 86 | INGREDIENT LAITIER ENRICHI EN LIPIDES POLAIRES ET APPLICATIONS DE CELUI-CI | EP07787515.1 | 2007-07-13 | EP2068637A1 | 2009-06-17 | DALEMANS, Daniel; BLECKER, Christophe; BODSON, Pascal; DEROANNE, Claude; PAQUOT, Michel; DANTHINE, Sabine |
| A milk ingredient enriched in polar lipids, in particular in phospholipids and in sphingolipids, in which the percentage of phospholipids is greater than 10% by weight, relative to the weight of solids of the ingredient, method for obtaining same starting from pasteurized cream and use thereof in food and/or pharmaceutical products. | ||||||
| 87 | VISCERAL FAT ACCUMULATION INHIBITOR, AND AGENT FOR PROMOTING THE INCREASE IN AND/OR INHIBITING THE DECREASE IN BLOOD ADIPONECTIN LEVEL | EP07737233.2 | 2007-05-30 | EP2039365A1 | 2009-03-25 | KAWAKAMI, Hiroshi; HIGURASHI, Satoshi; MATSUYAMA, Hiroaki |
Disclosed is: a visceral fat accumulation inhibitor or a food or drink for inhibiting the accumulation of a visceral fat, which composes a fat globule membrane component as an active ingredient; or a agent or food or drink for promoting the increase in the blood adiponection level and/or inhibiting the decrease in the blood adiponection level, which composes a fat globule membrane component as an active ingredient. A fat globule membrane component can inhibit the accumulation of a visceral fat, and/or can promote the increase in or inhibit the decrease in the blood adiponection level. |
||||||
| 88 | BETA-SERUM DAIRY PRODUCTS, NEUTRAL LIPID-DEPLETED AND/OR POLAR LIPID-ENRICHED DAIRY PRODUCTS, AND PROCESSES FOR THEIR PRODUCTION | EP05801035.6 | 2005-10-12 | EP1814399A1 | 2007-08-08 | Katrina Fletcher; Owen, John Catchpole; John Bertram Grey; Mark Pritchard |
| Processes for producing dairy products having lower levels of neutral lipids, and/or higher levels of polar lipids, by extraction using near critical carbon dioxide or dimethyl ether. These products may be used as ingredients in infant formulas. Infant formulas containing beta-serum are also claimed. 'Beta-serum' means an aqueous dairy ingredient separated from dairy streams containing greater than 60% fat which have been through phase inversion from an oil-in- water to a water-in-oil emulsion, such as the serum produced during the production of butter oil. | ||||||
QQ群二维码
意见反馈
意见反馈